Connecting you and your patients to information that matters

Image is an actor portrayal.

Sign up to stay up to date on C3G and primary IC-MPGN

Although C3G and primary IC-MPGN are rare, more information and resources are becoming available. Don’t miss out—sign up today and help keep your practice and your patients up to date.

    *Required
    By clicking "Submit," I consent to receive communications from Apellis Pharmaceuticals, Inc. about its programs, products, services, and research opportunities. I understand I can opt-out anytime and can refer to the Apellis Privacy Policy for more information.

    Thank you for signing up

    Be on the lookout for additional C3G and primary IC-MPGN information and resources as they become available.

    Go to home page Link

    Apellis is committed to providing you and your patients with information and resources on complement-driven diseases such as C3G and primary IC-MPGN

    Continue exploring C3G and primary IC-MPGN

    Learn more Link

    C3=complement component 3; IC-MPGN=immune complex membranoproliferative glomerulonephritis.